Ann Marie Sastry, CHIEF EXECUTIVE OFFICER at Amesite Inc. (AMST), bought 174,216 shares at $1.44 ($250K) on 2026-04-28, disclosed to the SEC on 2026-05-18.
CEO Ann Marie Sastry executed the largest insider purchase in the company's history, buying 174,216 shares at $1.44 to signal confidence in the AI healthcare platform. This move comes as the stock has plummeted over 50% in the last 90 days, potentially offering a contrarian entry point near the 52-week low.
AMST is currently trading at $0.83, representing a 52.84% decline over the last 30 days and a 54.14% drop over the last 90 days. The stock is trading just 5.05% above its 52-week low of $0.79 and 82.64% below its 52-week high of $4.78.
A major catalyst is the recent announcement of a new enterprise deal for NurseMagic AI, which sent shares soaring 150% on May 20. Additionally, the company completed a $6M registered direct offering on April 28 at $1.435 per share, providing capital for growth.
The stock carries a short interest of 6.49% on the float, which could exacerbate volatility. Recent news articles explicitly warn that there are "ample reasons to avoid chasing the momentum" in AMST shares despite the recent surge.
Something here stands out, but not much.
| Filing → |
| AMST | BUY | 2023-03-08 | $3K | — | Filing → |
| AMST | BUY | 2023-03-03 | $6K | — | Filing → |
| AMST | BUY | 2023-03-01 | $6K | — | Filing → |